DIMO Healthcare with ZEISS unveil cutting-edge solution for cataract patients

From left: Bangladesh Eye Hospital and Institute Assistant Professor Dr. Ishtiaque Anwar, DIMO Executive Director Wijith Pushpawela, ZEISS Group Regional Head – SAARC Vikas Saxena, DIMO Chairman Ranjith Pandithage, Managing Director and Group CEO Gahanath Pandithage, and DIMO Healthcare COO Priyantha Dissanayake

DIMO Healthcare, the healthcare arm of the leading diversified conglomerate DIMO, together with ZEISS, a globally renowned technology enterprise operating in the optics and optoelectronics sphere, has introduced ZEISS CT LUCIA 621P Monofocal Intraocular Lens (IOL) to Sri Lanka. 

This innovation redefines cataract surgery procedures, offering enhanced visual outcomes for patients.   

As part of the ZEISS cataract workflow solution portfolio, the CT LUCIA 621P Monofocal IOL will also empower surgeons with the tools needed to deliver optimised visual outcomes for cataract patients. The fully preloaded injector will make the surgical procedure intuitive, smooth, and controlled, reducing the risk of complications. The architecture of the IOL has been meticulously designed to promote effortless centring and optimise direct contact with the capsular bag. This deliberate design not only assures stability but also maintains a consistent placement within the eye’s natural bag, offering patients a dependable and enduring solution.  

ZEISS Group Regional Head – SAARC Vikas Saxena said: “We are thrilled to introduce the ZEISS CT LUCIA 621P Monofocal IOL to the Sri Lankan market. This innovative IOL is the result of our unwavering commitment to advancing eye care technology and enhancing the quality of life for cataract patients. With its patented ZO Asphericity Concept and user-friendly design, we believe this product will empower surgeons in Sri Lanka to deliver exceptional visual outcomes. ZEISS has a long-standing reputation for delivering cutting-edge optical solutions, and this latest innovation solidifies our commitment to providing state-of-the-art technology to the ophthalmic community in Sri Lanka.” 

DIMO Executive Director Wijith Pushpawela who oversees the Healthcare arm of the Group said: “DIMO Healthcare is always at the forefront of bringing the latest technology to the country, to fuel the dreams and aspirations of Sri Lankans while Building a Healthier Nation. It is indeed a privilege to partner with Carl Zeiss, a pioneer in the science of optics worldwide, to introduce the latest innovations like the ZEISS CT LUCIA 621P Monofocal IOL to Sri Lanka. As the local representative of ZEISS in Sri Lanka, DIMO Healthcare has introduced the country’s first Wide Angle Fundus Phototherapy and Multi Spot Green Laser therapeutic microscope, offering healthcare solutions for a diverse spectrum of patients, and enabling greater convenience for both healthcare providers and their patients.”   

The ZEISS CT LUCIA 621P Monofocal IOL is a remarkable addition to the world of ophthalmology, featuring the patented ZEISS Optic (ZO) Asphericity Concept. This innovative technology is designed to address a wide range of spherical aberrations, ensuring superior visual outcomes even in cases of potential lens misalignments and decentration. This ground-breaking feature sets the CT LUCIA 621P apart as a true game-changer in the field of cataract surgery. 

In addition to this latest launch, ZEISS will also introduce technologically advanced IOLs like Trifocal and Extended Depth of Focus (EDOF) in a phased manner, which will ensure the best patient outcomes for ophthalmologists in Sri Lanka. 

Cataract surgery is one of the most common surgical procedures in the world, and the introduction of the ZEISS CT LUCIA 621P Monofocal IOL promises to make this procedure even more effective and reliable.